Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
38,150
Views
250
CrossRef citations to date
0
Altmetric
Coronaviruses
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
Li Zhanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
, Qianqian Lia Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China;b Jiangsu Recbio Technology Co., Ltd., Taizhou, People’s Republic of ChinaView further author information
, Ziteng Lianga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China;c Graduate School of Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
, Tao Lia Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
, Shuo Liua Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
, Qianqian Cuia Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
, Jianhui Niea Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
, Qian Wud Translational Medicine Institute, The First People’s Hospital of Chenzhou, University of South China, Chenzhou, People’s Republic of ChinaView further author information
, Xiaowang Qud Translational Medicine Institute, The First People’s Hospital of Chenzhou, University of South China, Chenzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Weijin Huanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Youchun Wanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-9769-5141View further author information
show allhttps://orcid.org/0000-0001-9769-5141View further author information
Pages 1-5
|
Received 07 Dec 2021, Accepted 08 Dec 2021, Published online: 21 Dec 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.